What is the price target for PHA stock?
8 analysts have analysed PHA.CA and the average price target is 0.2 CAD. This implies a price increase of 716% is expected in the next year compared to the current price of 0.025.
PREMIER HEALTH OF AMERICA IN (PHA.CA) Forecast, Price Target & Analyst Ratings
TSX-V:PHA • CA74052G1063
Current stock price
0.025 CAD
+0.01 (+25%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PREMIER HEALTH OF AMERICA IN (PHA.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$0.20
Upside
+ 716.00%
From current price of CA$0.03 to mean target of CA$0.20, Based on 8 analyst forecasts
Low
CA$0.20
Median
CA$0.20
High
CA$0.21
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for PHA.CA. The average price target is 0.2 CAD. This implies a price increase of 716% is expected in the next year compared to the current price of 0.025.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
40.00%
PHA.CA was analyzed by 8 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about PHA.CA.
In the previous month the buy percentage consensus was at a similar level.
PHA.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-05-20 | Acumen Capital | Downgrade | Buy |
| 2021-08-30 | Acumen Capital | Downgrade | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 19, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 90.39M 12.28% | 158.191M 75.01% | 101.969M -35.54% | 134.15M 31.56% | 141.95M 5.81% | |
| EBITDA YoY % growth | 7.778M 35.03% | 6.025M -22.54% | -1.527M -125.34% | 6.901M 551.93% | 7.402M 7.26% | |
| EBIT YoY % growth | 3.329M 42.43% | -787K -123.64% | -9.733M -1,136.72% | 14.438M 248.34% | N/A | |
| Operating Margin | 3.68% | -0.50% | -9.55% | 10.76% | N/A | |
| EPS YoY % growth | N/A 243.33% | N/A -2,040.00% | N/A 40.21% | -0.12 -0.86% | -0.12 |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PREMIER HEALTH OF AMERICA IN / PHA.CA Forecast FAQ
When does PREMIER HEALTH OF AMERICA IN (PHA.CA) report earnings?
PREMIER HEALTH OF AMERICA IN (PHA.CA) will report earnings on 2026-05-19.
How many analysts have analysed PREMIER HEALTH OF AMERICA IN (PHA.CA)?
The number of analysts covering PREMIER HEALTH OF AMERICA IN (PHA.CA) is 8.